Articlenpj antimicrobials and resistance2026
Genomic landscape of antimicrobial resistance in India: findings from a multi-species surveillance study.
Article in npj antimicrobials and resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emerging burden of antimicrobial resistance in Indian hospitals: A review.Bioinformation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Antimicrobial resistance (AMR) is a major public health threat, especially in low- and middle-income countries (LMICs), where large datasets linking antimicrobial susceptibility testing (AST) with genomic data remain limited. We analyzed AST results and whole genomes from 266 resistant bacterial isolates representing diverse species and specimen sources, collected from Northern and Western India between 2022 and 2024. Correlation of genomic resistance predictions with AST data revealed an overprediction of resistance by genomic methods. To our knowledge, this is the first study to systematically examine these discrepancies across multiple antibiotic-pathogen combinations in India and to identify promising targets for genomic resistance prediction. We also investigated the predominant antibiotic resistance genes (ARGs), plasmids, and other mobile genetic elements associated with them. Overall, our findings contribute meaningfully to the genomic epidemiology of AMR in India and support the development of molecular diagnostics for antimicrobial resistance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.